Donna Shoupe

No ORCID on file · 14 papers in corpus
book-chapter 2023
Management of Pelvic Pain
·doi:10.1007/978-3-031-14881-1_86
book-chapter 2022
Management of Pelvic Pain
·doi:10.1007/978-3-319-17002-2_86-2
article 2022
SUBSTANTIAL VARIABILITY IN OVARIAN CONSERVATION AT HYSTERECTOMY FOR ENDOMETRIAL HYPERPLASIA
·doi:10.1016/j.fertnstert.2022.08.670
article 2019
Patterns of utilization and outcomes of ovarian conservation for young women with minimum-risk endometrial cancer
·doi:10.1016/j.ygyno.2019.04.246
book-chapter 2017
Management of Pelvic Pain
·doi:10.1007/978-3-319-17798-4_86
article 2013
Long-Term Mortality Associated With Oophorectomy Compared With Ovarian Conservation in the Nurses' Health Study
·doi:10.1097/aog.0b013e3182864350

OBJECTIVE: To report long-term mortality after oophorectomy or ovarian conservation at the time of hysterectomy in subgroups of women based on age at the time of surgery, use of estrogen therapy, presence of risk factors for coronary heart …

article 2009
Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study
·doi:10.1097/aog.0b013e3181a11c64

OBJECTIVE: To report long-term health outcomes and mortality after oophorectomy or ovarian conservation. METHODS: We conducted a prospective, observational study of 29,380 women participants of the Nurses' Health Study who had a hysterectom…

book-chapter 2006
Long-Acting Progestin Injectables
·doi:10.1007/978-1-59745-150-5_7

Depo-Provera® (depot medroxyprogesterone acetate [DMPA]) is an extremely effective contraceptive agent. Since its introduction into the market in the 1960s, DMPA has been used for a variety of gynecological conditions including endometriosi…

article 2005
Ovarian Conservation at the Time of Hysterectomy for Benign Disease
·doi:10.1097/01.aog.0000186258.37099.a2

Parker, William H. MD; Broder, Michael S. MD, MPH; Berek, Jonathan S. MD, MMSc; Liu, Zhimei PhD; Shoupe, Donna MD; Farquhar, Jonathan S. MD Author Information

article 2005
Ovarian Conservation at the Time of Hysterectomy for Benign Disease
·doi:10.1097/01.aog.0000190481.84868.7d

Parker, William H. MD; Broder, Michael S. MD, MPH; Liu, Zhimei PhD; Shoupe, Donna MD; Farquhar, Cindy MD; Berek, Jonathan S. MD, MMSc Author Information

article 2001
Hysteroscopic view 6 to 30 months after cryoablation in 20 patients
·doi:10.1016/s1074-3804(01)80086-4
article 2001
Month data from multicenter study of her option uterine cryoablation versus rollerball electroablation in women with menorrhagia
·doi:10.1016/s1074-3804(01)80088-8
article 2001
Uterine cryoablation therapy in women with menorrhagia
·doi:10.1016/s1074-3804(01)80089-x
review 2000
Hysterectomy or an Alternative?
Hospital practice (1995) ·doi:10.3810/hp.2000.09.213

Even though hysterectomy remains an appealing solution for a number of nonmalignant gynecologic conditions, patients are often scheduled for surgery without proper evaluation or consideration of an alternative. For symptoms associated with …